Global Nucleic Acid Amplification Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Nucleic Acid Amplification Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Nucleic Acid Amplification Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Target Amplification Systems
  • 1.4.3 Probe Amplification Systems
  • 1.4.4 Signal Amplification
• 1.5 Market by Application
  • 1.5.1 Global Nucleic Acid Amplification Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Infectious Diseases
  • 1.5.3 Cancer
  • 1.5.4 Personalized Medicine
  • 1.5.5 Genetic and Mitochondrial Disorders
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Nucleic Acid Amplification Testing Market Perspective (2015-2026)
• 2.2 Global Nucleic Acid Amplification Testing Growth Trends by Regions
  • 2.2.1 Nucleic Acid Amplification Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nucleic Acid Amplification Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nucleic Acid Amplification Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Nucleic Acid Amplification Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Nucleic Acid Amplification Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Nucleic Acid Amplification Testing Players by Market Size
  • 3.1.1 Global Top Nucleic Acid Amplification Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Nucleic Acid Amplification Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Nucleic Acid Amplification Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Nucleic Acid Amplification Testing Market Concentration Ratio
  • 3.2.1 Global Nucleic Acid Amplification Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Nucleic Acid Amplification Testing Revenue in 2019
• 3.3 Nucleic Acid Amplification Testing Key Players Head office and Area Served
• 3.4 Key Players Nucleic Acid Amplification Testing Product Solution and Service
• 3.5 Date of Enter into Nucleic Acid Amplification Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Nucleic Acid Amplification Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Nucleic Acid Amplification Testing Market Size by Application (2015-2020)
• 5.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nucleic Acid Amplification Testing Market Size (2015-2020)
• 6.2 Nucleic Acid Amplification Testing Key Players in North America (2019-2020)
• 6.3 North America Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 6.4 North America Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Nucleic Acid Amplification Testing Market Size (2015-2020)
• 7.2 Nucleic Acid Amplification Testing Key Players in Europe (2019-2020)
• 7.3 Europe Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 7.4 Europe Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Nucleic Acid Amplification Testing Market Size (2015-2020)
• 8.2 Nucleic Acid Amplification Testing Key Players in China (2019-2020)
• 8.3 China Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 8.4 China Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Nucleic Acid Amplification Testing Market Size (2015-2020)
• 9.2 Nucleic Acid Amplification Testing Key Players in Japan (2019-2020)
• 9.3 Japan Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 9.4 Japan Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Nucleic Acid Amplification Testing Market Size (2015-2020)
• 10.2 Nucleic Acid Amplification Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Nucleic Acid Amplification Testing Market Size (2015-2020)
• 11.2 Nucleic Acid Amplification Testing Key Players in India (2019-2020)
• 11.3 India Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 11.4 India Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Nucleic Acid Amplification Testing Market Size (2015-2020)
• 12.2 Nucleic Acid Amplification Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Nucleic Acid Amplification Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Nucleic Acid Amplification Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 F. Hoffmann-La Roche
  • 13.1.1 F. Hoffmann-La Roche Company Details
  • 13.1.2 F. Hoffmann-La Roche Business Overview
  • 13.1.3 F. Hoffmann-La Roche Nucleic Acid Amplification Testing Introduction
  • 13.1.4 F. Hoffmann-La Roche Revenue in Nucleic Acid Amplification Testing Business (2015-2020))
  • 13.1.5 F. Hoffmann-La Roche Recent Development
• 13.2 Becton
  • 13.2.1 Becton Company Details
  • 13.2.2 Becton Business Overview
  • 13.2.3 Becton Nucleic Acid Amplification Testing Introduction
  • 13.2.4 Becton Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.2.5 Becton Recent Development
• 13.3 Dickinson and Company
  • 13.3.1 Dickinson and Company Company Details
  • 13.3.2 Dickinson and Company Business Overview
  • 13.3.3 Dickinson and Company Nucleic Acid Amplification Testing Introduction
  • 13.3.4 Dickinson and Company Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.3.5 Dickinson and Company Recent Development
• 13.4 Beckman Coulter
  • 13.4.1 Beckman Coulter Company Details
  • 13.4.2 Beckman Coulter Business Overview
  • 13.4.3 Beckman Coulter Nucleic Acid Amplification Testing Introduction
  • 13.4.4 Beckman Coulter Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.4.5 Beckman Coulter Recent Development
• 13.5 Abbott Laboratories
  • 13.5.1 Abbott Laboratories Company Details
  • 13.5.2 Abbott Laboratories Business Overview
  • 13.5.3 Abbott Laboratories Nucleic Acid Amplification Testing Introduction
  • 13.5.4 Abbott Laboratories Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.5.5 Abbott Laboratories Recent Development
• 13.6 Illumina
  • 13.6.1 Illumina Company Details
  • 13.6.2 Illumina Business Overview
  • 13.6.3 Illumina Nucleic Acid Amplification Testing Introduction
  • 13.6.4 Illumina Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.6.5 Illumina Recent Development
• 13.7 Siemens Healthineers
  • 13.7.1 Siemens Healthineers Company Details
  • 13.7.2 Siemens Healthineers Business Overview
  • 13.7.3 Siemens Healthineers Nucleic Acid Amplification Testing Introduction
  • 13.7.4 Siemens Healthineers Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.7.5 Siemens Healthineers Recent Development
• 13.8 bioMerieux
  • 13.8.1 bioMerieux Company Details
  • 13.8.2 bioMerieux Business Overview
  • 13.8.3 bioMerieux Nucleic Acid Amplification Testing Introduction
  • 13.8.4 bioMerieux Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.8.5 bioMerieux Recent Development
• 13.9 Novartis
  • 13.9.1 Novartis Company Details
  • 13.9.2 Novartis Business Overview
  • 13.9.3 Novartis Nucleic Acid Amplification Testing Introduction
  • 13.9.4 Novartis Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.9.5 Novartis Recent Development
• 13.10 Bio-Rad Laboratories
  • 13.10.1 Bio-Rad Laboratories Company Details
  • 13.10.2 Bio-Rad Laboratories Business Overview
  • 13.10.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Introduction
  • 13.10.4 Bio-Rad Laboratories Revenue in Nucleic Acid Amplification Testing Business (2015-2020)
  • 13.10.5 Bio-Rad Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer